Across TCGA pan-cancer cohorts, MIR574 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR574 data layer.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR574 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR574 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.
CHOL, COAD, and ACC are the cancer types where MIR574 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.